Developments in Cancer Vaccine Industry (Technical Insights)

 

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research service analyses the latest developments that has occurred in the field of cancer vaccines, both from a technology and industry perspective.

Table of Contents

Developments in Cancer Vaccine Industry (Technical Insights), Executive SummaryResearch Scope and MethodologyResearch ScopeResearch MethodologyIndustry Overview; Trends; and Key FindingsIndustry Overview and TrendsNoteworthy DevelopmentsDevelopments in Cancer Vaccine Industry (Technical Insights), Technology Adoption Factor AnalysisTechnology PrimerCancer--A Malignant MaladyThe Immune Escape of CancerCancer Vaccines--An IntroductionTherapeutic Vaccines in the Spotlight--Waking up the Immune System to Treat CancerTechnology and Industry Drivers; ChallengesTechnology and Industry DriversTechnology and Industry Barriers and ChallengesStrategic Evaluation of the Competitive EnvironmentA Strategic Evaluation of the Cancer Vaccine Space–SWOT AnalysisKey Collaborations and Corporate Deals in the Cancer Vaccine Sector--An Impact AnalysisPipeline Insight--Cancer Vaccines in the LeadCurrent Trends; Future Outlook; and Strategic Recommendations (Analyst's Perspectives)Cancer Vaccine Industry Trends–A Turbulent Path toward SuccessCancer Vaccine Future Outlook–From Pipeline to Approved ProductsStrategic Recommendations--Converting Challenge to SuccessDevelopments in Cancer Vaccine Industry (Technical Insights), On-Going R & D Highlights in the Cancer Vaccine SpaceCorporate Profiles--WorldFrom Cell-Lines to off-the-shelf Immunotherapies–Creating an Impact in Cancer Therapeutics--USALiposomal Vaccines–Leading the Way in NSCLC Therapeutics--USAVaccine to Attack the Pregnancy Hormone–A Novel Theme to Tame Cancer--USAYeast Vector-Based Vaccines–A Novel Paradigm of Cancer Vaccine Development--USARNA-Loaded Dendritic Cells--Paving the Way for a New Generation of Personalized Cancer Vaccines--USAConsolidated Immunotherapeutic Technologies as a Dynamic Tool to Combat Cancer--DenmarkA Cocktail of Approaches to Wake up the Immune System against Cancer--USAViral Vector Vaccines Inspire a Robust Mechanism of Immunization against a Wide Spectrum of Cancer Indications--FranceMultiantigen Viral Vector Vaccines–Generating Broader Immune Responses--USAListeria-Based Vaccines–A Potent Bacterium-Based Stimulation of Immune System--USATelomerase Targeting Vaccines–Inciting Optimism to Deliver Targeted Cancer Therapy--USAAcademic Profiles--USAEncouraging Results Reveal Pioneering Pancreatic Cancer TreatmentVaccine Strategy Aims at Molecular Targets for Head and Neck CancerEmbryonic Stem Cells Suggest an Exciting Possibility toward Lung Cancer Treatment in MiceResearchers Embark on a Novel Approach to Prevent Breast CancerDevelopments in Cancer Vaccine Industry (Technical Insights), Intellectual Property (IP) Scenario; Key ContactsThe IP ScenarioKey Industry PatentsKey Academic PatentsKey ContactsKey Industry ContactsKey Academic ContactsDevelopments in Cancer Vaccine Industry (Technical Insights), Decision Support Database TablesDatabase TablesPharmaceutical R&D Expenditure--World (2002 to 2012)Mortality of Prostrate Cancer--World (2002 to 2012)Mortality of Lung Cancer--World (2002 to 2012)Incidence of Breast Cancer--World (2002 to 2012)Incidence of Colon Rectum Cancer--World (2002 to 2012)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 10-Nov-17

Region : Global

Release Date : 10-Nov-17

Region : Global

Release Date : 09-Nov-17

Region : Global

Release Date : 03-Nov-17

Region : Global

Release Date : 31-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.